Directing the use of DDR kinase inhibitors in cancer treatment
Author:
Affiliation:
1. The CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
Funder
Breast Cancer Now
Cancer Research UK
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1389895
Reference129 articles.
1. Genome maintenance mechanisms for preventing cancer
2. The DNA damage response and cancer therapy
3. Targeting the ATR-CHK1 Axis in Cancer Therapy
4. Cell cycle proteins as promising targets in cancer therapy
5. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Increasing DNA damage sensitivity through corylin-mediated inhibition of homologous recombination;Biomedicine & Pharmacotherapy;2024-07
2. PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation;Frontiers in Oncology;2024-05-14
3. Recent Progress in DNA Damage Response-Targeting PROTAC Degraders;Journal of Medicinal Chemistry;2024-04-25
4. Discovery of Novel Heterotricyclic Compounds as DNA-Dependent Protein Kinase (DNA-PK) Inhibitors with Enhanced Chemosensitivity, Oral Bioavailability, and the Ability to Potentiate Cancer Immunotherapy;Journal of Medicinal Chemistry;2024-04-08
5. Discovery of pyrido[3,2-d]pyrimidin-6(5H)-one derivatives as checkpoint kinase 1 (CHK1) inhibitors with potent antitumor efficacy;European Journal of Medicinal Chemistry;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3